Originally founded in 1972 as a small team of fewer than 10 people, the department has grown to include seven divisions with 285 faculty and staff.
Northwestern investigators have developed a deep learning-based method that can predict cognitive function capacity based on brain shape and structure, detailed in a study published in Scientific Reports.
Northwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell proliferation and survival in acute myeloid leukemia, according to findings published in Blood.
Northwestern Medicine scientists have identified a gene that is responsible for activating an aggressive subtype of small-cell lung cancer for which there is no current effective treatment.
Sunny Abdelmageed, a third-year medical student, is interested in research projects that seek to improve outcomes and preserve brain function for patients.
Susan Quaggin, MD, has been presented one of The American Heart Association’s 2022 Distinguished Scientist awards, which honor members who have significantly advanced the understanding of cardiovascular, stroke or brain health.
After 28 years of leadership, M. Marsel Mesulam, MD, has announced that he will be stepping down as director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease; he will be succeeded by Robert Vassar, PhD.
The Kimberly Querrey Summer Research Program combines intensive, hands-on biomedical research training with academic and professional development opportunities to support the next generation of scientists.
Northwestern Medicine investigators have developed a novel approach for designing and testing new protein folds, which could be used to develop new therapeutics.
Patients with acute myeloid leukemia show large-scale genomic mutations and altered DNA folding patterns that could help identify potential therapeutic targets, according to a Northwestern Medicine study published in Nature.